1. Home
  2. CRSR vs ARDX Comparison

CRSR vs ARDX Comparison

Compare CRSR & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corsair Gaming Inc.

CRSR

Corsair Gaming Inc.

BUY

Current Price

$13.37

Market Cap

1.2B

Sector

Technology

ML Signal

BUY

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$3.42

Market Cap

975.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSR
ARDX
Founded
1994
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
975.9M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
CRSR
ARDX
Price
$13.37
$3.42
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$8.50
$15.14
AVG Volume (30 Days)
1.1M
3.9M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
87.37
N/A
EPS
0.17
N/A
Revenue
$1,472,480,000.00
$2,607,000.00
Revenue This Year
N/A
$37.75
Revenue Next Year
$6.90
$34.24
P/E Ratio
$79.82
N/A
Revenue Growth
11.86
N/A
52 Week Low
$4.48
$3.34
52 Week High
$14.98
$8.40

Technical Indicators

Market Signals
Indicator
CRSR
ARDX
Relative Strength Index (RSI) 58.32 24.11
Support Level $8.18 N/A
Resistance Level $14.98 $3.92
Average True Range (ATR) 0.53 0.12
MACD 0.06 0.01
Stochastic Oscillator 75.11 14.53

Price Performance

Historical Comparison
CRSR
ARDX

About CRSR Corsair Gaming Inc.

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the United States (U.S.), Americas (excluding U.S.) , Europe and the Middle East, and the Asia Pacific, of which maximum revenue is generated from United States (U.S.).

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: